In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Nordic Capital sells, then re-buys Nycomed Holding
21 Apr 2005
Investment bank Nordic Capital has entered into a definitive agreement to sell Nycomed Holding AS (the old Nycomed Pharma; pharmaceutical in-licensing and development) to a new investment company owned by CSFB Private Equity, Blackstone Capital Partners, and NIB Capital Private Equity. The purchase price is approximately $1.1bn, roughly 2 times Nycomed's 2001 sales, and is split evenly between debt and equity.
Payment Includes Cash
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?